Clinical trials
Completed Carcinoma, Renal Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
910 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 27 |
| 2001 | 20 |
| 2002 | 21 |
| 2003 | 23 |
| 2004 | 42 |
| 2005 | 38 |
| 2006 | 52 |
| 2007 | 56 |
| 2008 | 51 |
| 2009 | 41 |
| 2010 | 42 |
| 2011 | 41 |
| 2012 | 40 |
| 2013 | 26 |
| 2014 | 33 |
| 2015 | 36 |
| 2016 | 60 |
| 2017 | 32 |
| 2018 | 40 |
| 2019 | 40 |
| 2020 | 34 |
| 2021 | 24 |
| 2022 | 20 |
| 2023 | 16 |
| 2024 | 6 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 910 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 69 |
| Pfizer | 52 |
| Novartis Pharmaceuticals | 26 |
| Bayer | 22 |
| Bristol-Myers Squibb | 21 |
| Memorial Sloan Kettering Cancer Center | 21 |
| GlaxoSmithKline | 19 |
| M.D. Anderson Cancer Center | 17 |
| Case Comprehensive Cancer Center | 13 |
| Radboud University Medical Center | 12 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 910 |
| Kidney Neoplasms | 249 |
| Melanoma | 122 |
| Carcinoma, Non-Small-Cell Lung | 117 |
| Neoplasms | 82 |
| Breast Neoplasms | 76 |
| Neoplasm Metastasis | 66 |
| Urinary Bladder Neoplasms | 63 |
| Carcinoma, Hepatocellular | 59 |
| Stomach Neoplasms | 56 |
Trials
Showing 26 to 50 of 910. Each trial links to its page on Pharma Observatory.
810 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.